Investor
Accelerating the translation of academic research into innovative companies focused on addressing chronic diseases and high-tech spin-offs.
Amsterdam
Who they are
The TTT Medtech fund, part of the Thematic Technology Transfer (TTT) program, is a collaborative initiative in the Netherlands designed to support the commercialization of deep tech research into high-impact spin-offs. It focuses on technology-driven medical solutions, guiding researchers through validation and company formation, and providing initial financing. In December 2025, the TTT Medtech fund, along with the Smart Industry TTT fund, was acquired by 819 Capital Partners from Innovation Industries, transferring 23 portfolio companies while retaining capacity for future investments. The program emphasizes translational innovation, fostering projects with significant clinical and societal impact, particularly in chronic diseases.
What they invest in
Where to find them
Loading nearby…